REVELATION BIOSCIENCES, INC. Fair Value Adjustment of Warrants
REVELATION BIOSCIENCES, INC. (REVB) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $0.00.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$87.00.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$611.00.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2025 was -$2.16K.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2024 was -$81.44K.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2023 was -$8.33M.
- REVELATION BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2022 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$87.00 derived: sum of 3 quarters · filed 2026-08-06 | -$698.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$87.00 derived: sum of 2 quarters · filed 2026-05-07 | -$698.00 derived: sum of 3 quarters · filed 2026-05-07 | -$742.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$87.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$698.00 derived: sum of 2 quarters · filed 2026-02-26 | -$742.00 derived: sum of 3 quarters · filed 2026-08-06 | -$2.16K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$611.00 10-Q · filed 2025-11-06 | -$655.00 derived: sum of 2 quarters · filed 2026-08-06 | -$2.07K 10-Q · filed 2025-11-06 | -$4.63K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$44.00 10-Q · filed 2026-08-06 | -$1.46K 10-Q · filed 2026-08-06 | -$4.02K derived: sum of 3 quarters · filed 2026-08-06 | -$10.06K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.42K 10-Q · filed 2026-05-07 | -$3.97K derived: sum of 2 quarters · filed 2026-05-07 | -$10.02K derived: sum of 3 quarters · filed 2026-05-07 | -$14.43K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.60K derived: sum of 2 quarters · filed 2026-02-26 | -$13.01K derived: sum of 3 quarters · filed 2026-02-26 | -$81.44K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$6.04K 10-Q · filed 2025-11-06 | -$10.46K derived: sum of 2 quarters · filed 2025-11-06 | -$78.88K 10-Q · filed 2025-11-06 | -$147.09K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$4.42K 10-Q · filed 2025-08-08 | -$72.84K 10-Q · filed 2025-08-08 | -$141.04K derived: sum of 3 quarters · filed 2025-08-08 | -$233.61K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$68.43K 10-Q · filed 2025-05-08 | -$136.63K derived: sum of 2 quarters · filed 2025-05-08 | -$229.19K derived: sum of 3 quarters · filed 2025-05-08 | -$652.43K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$68.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$160.76K derived: sum of 2 quarters · filed 2025-03-06 | -$584.00K derived: sum of 3 quarters · filed 2025-03-06 | -$8.33M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$92.56K 10-Q · filed 2024-11-08 | -$515.80K derived: sum of 2 quarters · filed 2024-11-08 | -$8.26M 10-Q · filed 2024-11-08 | -$8.26M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$423.24K 10-Q/A · filed 2024-09-23 | -$8.17M 10-Q/A · filed 2024-09-23 | -$8.17M derived: sum of 3 quarters · filed 2024-09-23 | -$8.17M derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-03-31 | -$7.74M 10-Q/A · filed 2024-09-23 | -$7.74M derived: sum of 2 quarters · filed 2024-09-23 | -$7.74M derived: sum of 3 quarters · filed 2024-09-23 | -$7.74M derived: sum of 4 quarters · filed 2024-09-23 |
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | $0.00 derived: sum of 2 quarters · filed 2024-09-23 | $0.00 derived: sum of 3 quarters · filed 2024-09-23 | $0.00 10-K/A · filed 2024-09-23 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $246.84K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $246.84K derived: sum of 3 quarters · filed 2023-08-11 | $161.80K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-22 | $246.84K derived: sum of 2 quarters · filed 2023-05-22 | $161.80K derived: sum of 3 quarters · filed 2023-05-22 | $652.75K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $246.84K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $161.80K derived: sum of 2 quarters · filed 2022-04-15 | $652.75K derived: sum of 3 quarters · filed 2022-04-15 | -$1.01M 10-K · filed 2022-04-15 |
| 2021-09-30 | -$85.04K 10-Q · filed 2021-10-29 | $405.91K derived: sum of 2 quarters · filed 2021-10-29 | -$1.26M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $490.95K 10-Q · filed 2021-08-23 | -$1.17M 10-Q · filed 2021-08-23 | ||
| 2021-03-31 | -$1.66M 10-Q · filed 2021-06-22 | |||
| 2020-12-31 | $1.49M 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |